LDLR and PCSK9 3′ UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach

被引:4
|
作者
de Freitas, Renata Caroline Costa [1 ,2 ]
Bortolin, Raul Hernandes [1 ,3 ]
Borges, Jessica Bassani [4 ]
de Oliveira, Victor Fernandes [1 ]
Dagli-Hernandez, Carolina [1 ]
Marcal, Elisangela da Silva Rodrigues [1 ,5 ]
Bastos, Gisele Medeiros [4 ]
Goncalves, Rodrigo Marques [6 ]
Faludi, Andre Arpad [6 ]
Silbiger, Vivian Nogueira [7 ,8 ]
Luchessi, Andre Ducati [7 ,8 ]
Hirata, Rosario Dominguez Crespo [1 ]
Hirata, Mario Hiroyuki [1 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Ave Prof Lineu Prestes 580, Sao Paulo, SP, Brazil
[2] Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA
[3] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[4] Hosp Beneficiencia Portuguesa Sao Paulo, Dept Res, BR-01323001 Sao Paulo, Brazil
[5] Inst Cardiol Dante Pazzanese, Lab Mol Res Cardiol, BR-04012909 Sao Paulo, Brazil
[6] Inst Cardiol Dante Pazzanese, Med Div, BR-04012909 Sao Paulo, Brazil
[7] Univ Fed Rio Grande do Norte, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-59012570 Natal, Brazil
[8] Univ Fed Rio Grande do Norte, Grad Program Biotechnol, Northeast Biotechnol Network RENORBIO, BR-59078900 Natal, Brazil
基金
巴西圣保罗研究基金会;
关键词
Familial hypercholesterolemia; LDLR; PCSK9; 3'UTR variants; mRNA:miRNA interaction; In silico analysis; FUNCTIONAL-ANALYSIS; GENETIC-VARIANTS; ASSOCIATION; DYSFUNCTION; PREDICTION; GUIDELINES; DISEASES;
D O I
10.1007/s11033-023-08784-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Familial hypercholesterolemia (FH) is caused by pathogenic variants in low-density lipoprotein (LDL) receptor (LDLR) or its associated genes, including apolipoprotein B (APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9), and LDLR adaptor protein 1 (LDLRAP1). However, approximately 40% of the FH patients clinically diagnosed (based on FH phenotypes) may not carry a causal variant in a FH-related gene. Variants located at 3' untranslated region (UTR) of FH-related genes could elucidate mechanisms involved in FH pathogenesis. This study used a computational approach to assess the effects of 3'UTR variants in FH-related genes on miRNAs molecular interactions and to explore the association of these variants with molecular diagnosis of FH.Methods and results Exons and regulatory regions of FH-related genes were sequenced in 83 FH patients using an exon-target gene sequencing strategy. In silico prediction tools were used to study the effects of 3<acute accent>UTR variants on interactions between miRNAs and target mRNAs. Pathogenic variants in FH-related genes (molecular diagnosis) were detected in 44.6% FH patients. Among 59 3'UTR variants identified, LDLR rs5742911 and PCSK9 rs17111557 were associated with molecular diagnosis of FH, whereas LDLR rs7258146 and rs7254521 and LDLRAP1 rs397860393 had an opposite effect (p < 0.05). 3<acute accent>UTR variants in LDLR (rs5742911, rs7258146, rs7254521) and PCSK9 (rs17111557) disrupt interactions with several miRNAs, and more stable bindings were found with LDLR (miR-4435, miR-509-3 and miR-502) and PCSK9 (miR-4796).Conclusion LDLR and PCSK9 3<acute accent>UTR variants disturb miRNA:mRNA interactions that could affect gene expression and are potentially associated with molecular diagnosis of FH.
引用
收藏
页码:9165 / 9177
页数:13
相关论文
共 50 条
  • [1] LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach
    Renata Caroline Costa de Freitas
    Raul Hernandes Bortolin
    Jessica Bassani Borges
    Victor Fernandes de Oliveira
    Carolina Dagli-Hernandez
    Elisangela da Silva Rodrigues Marçal
    Gisele Medeiros Bastos
    Rodrigo Marques Gonçalves
    Andre Arpad Faludi
    Vivian Nogueira Silbiger
    André Ducati Luchessi
    Rosario Dominguez Crespo Hirata
    Mario Hiroyuki Hirata
    Molecular Biology Reports, 2023, 50 : 9165 - 9177
  • [2] Functional Analysis of 3′UTR Variants at the LDLR and PCSK9 Genes in Patients with Familial Hypercholesterolemia
    Otero, Javier Sanguino
    Rodriguez-Jimenez, Carmen
    Mostaza Prieto, Jose
    Rodriguez-Antolin, Carlos
    Carazo Alvarez, Ana
    Arrieta Blanco, Francisco
    Rodriguez-Novoa, Sonia
    HUMAN MUTATION, 2024, 2024
  • [3] The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
    Meshkov, Alexey
    Ershova, Alexandra
    Kiseleva, Anna
    Zotova, Evgenia
    Sotnikova, Evgeniia
    Petukhova, Anna
    Zharikova, Anastasia
    Malyshev, Pavel
    Rozhkova, Tatyana
    Blokhina, Anastasia
    Limonova, Alena
    Ramensky, Vasily
    Divashuk, Mikhail
    Khasanova, Zukhra
    Bukaeva, Anna
    Kurilova, Olga
    Skirko, Olga
    Pokrovskaya, Maria
    Mikova, Valeriya
    Snigir, Ekaterina
    Akinshina, Alexsandra
    Mitrofanov, Sergey
    Kashtanova, Daria
    Makarov, Valentin
    Kukharchuk, Valeriy
    Boytsov, Sergey
    Yudin, Sergey
    Drapkina, Oxana
    GENES, 2021, 12 (01) : 1 - 17
  • [4] Functional analysis of PCSK9 3′UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia
    Los, Bruna
    Borges, Jessica B.
    Oliveira, Victor F.
    Freitas, Renata C. C.
    Dagli-Hernandez, Carolina
    Bortolin, Raul H.
    Goncalves, Rodrigo M.
    Faludi, Andre A.
    Rodrigues, Alice C.
    Bastos, Gisele M.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Hirata, Rosario D. C.
    Hirata, Mario H.
    EPIGENOMICS, 2021, 13 (10) : 779 - 791
  • [5] CHARACTERIZATION OF THE EFFECTS OF FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN LDLR ON PCSK9 BINDING
    Deng, Shijun
    Alabi, Adekunle
    Zhang, Dawei
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 55 - 55
  • [6] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Reddy, Lakshmi Lavanya
    Shah, Swarup A. V.
    Ponde, Chandrashekhar K.
    Dalal, Jamshed J.
    Jatale, Raj G.
    Dalal, Reeta J.
    Rajani, Rajesh M.
    Pillai, Sudhir K.
    Vanjani, Chander V.
    Ashavaid, Tester F.
    JOURNAL OF HUMAN GENETICS, 2021, 66 (10) : 983 - 993
  • [7] Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
    Hori, Mika
    Ohta, Naotaka
    Takahashi, Atsushi
    Masuda, Hiroaki
    Isoda, Rieko
    Yamamoto, Suguru
    Son, Cheol
    Ogura, Masatsune
    Hosoda, Kiminori
    Miyamoto, Yoshihiro
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2019, 289 : 101 - 108
  • [8] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Lakshmi Lavanya Reddy
    Swarup A. V. Shah
    Chandrashekhar K. Ponde
    Jamshed J. Dalal
    Raj G. Jatale
    Reeta J. Dalal
    Rajesh M. Rajani
    Sudhir K. Pillai
    Chander V. Vanjani
    Tester F. Ashavaid
    Journal of Human Genetics, 2021, 66 : 983 - 993
  • [9] VARIANTS AT ABCG5, LDLRAP1, LDLR AND PCSK9 3′UTR REGIONS AND HYPERCHOLESTEROLEMIA ASSOCIATION
    De Castro-Oros, I.
    Pueyo-Garcia, M.
    Lamiquiz-Moneo, I.
    Mateo-Gallego, R.
    Civeira, F.
    Pocovi, M.
    ATHEROSCLEROSIS, 2014, 235 (02) : E97 - E97
  • [10] PCSK9 in South African Variants of Familial Hypercholesterolemia
    Getz, Godfrey S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (22) : 2374 - 2375